Concepedia

Publication | Open Access

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

DOIFull Paper Access

288

Citations

49

References

2023

Year

Catherine J. Mummery, Anne Börjesson‐Hanson, D. Blackburn, Everard G.B. Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O. Rinne, Albert C. Ludolph,
Nature Medicine

References

YearCitations

Page 1